NCT03238924View on ClinicalTrials.gov

Prolonged Exposure and Oxytocin

PHASE2CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

January 1, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
PTSD
Interventions
DRUG

Oxytocin

40 IU oxytocin nasal spray, self-administered

DRUG

Placebos

Saline nasal spray, self-administered

All Listed Sponsors
lead

Medical University of South Carolina

OTHER

NCT03238924 - Prolonged Exposure and Oxytocin | Biotech Hunter | Biotech Hunter